DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $92,000 | +5.7% | 4,619 | +97.4% | 0.01% | +25.0% |
| Q2 2021 | $87,000 | +17.6% | 2,340 | -19.2% | 0.00% | 0.0% |
| Q1 2021 | $74,000 | -40.8% | 2,897 | -58.8% | 0.00% | -50.0% |
| Q3 2020 | $125,000 | +278.8% | 7,024 | +288.5% | 0.01% | +166.7% |
| Q1 2020 | $33,000 | -74.8% | 1,808 | -69.8% | 0.00% | -62.5% |
| Q4 2019 | $131,000 | +1210.0% | 5,990 | +877.2% | 0.01% | +700.0% |
| Q2 2019 | $10,000 | +11.1% | 613 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,000 | -25.0% | 613 | -47.4% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -29.4% | 1,165 | +8.4% | 0.00% | 0.0% |
| Q3 2018 | $17,000 | – | 1,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |